Stoneridge Investment Partners’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,061	Closed	-$204K	–	159
2024 Q4	$204K	Buy	5,061 +821	+19%	+$33.1K	0.07%	104
2024 Q3	$268K	Hold	4,240	–	–	0.1%	87
2024 Q2	$225K	Buy	+4,240	New	+$225K	0.09%	101